The evolving role for re-irradiation in the management of recurrent grade 4 glioma

Steven P. Howard, Andra Krauze, Mike D. Chan, Christina Tsien, Wolfgang A. Tome

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Although significant gains have been realized in the management of grade 4 glioma, the majority of these patients will ultimately suffer local recurrence within the prior field of treatment. Clearly, novel local treatment strategies are required to improve patient outcomes. Concerns of toxicity have limited enthusiasm for the utilization of re-irradiation as a treatment option. However, using modern imaging technology and precision radiotherapy delivery techniques re-irradiation has proven a feasible option achieving both a palliative benefit and prolongation of survival with low toxicity rates. The evolution of re-irradiation as a treatment modality for recurrent grade 4 glioma is reviewed. In addition, potential targeted radiosensitizers to be used in conjunction with re-irradiation are also discussed.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalJournal of Neuro-Oncology
DOIs
StateAccepted/In press - Apr 6 2017

Keywords

  • Central nervous system
  • Radiosensitizers
  • Re-irradiation
  • Recurrent grade 4 glioma

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Fingerprint Dive into the research topics of 'The evolving role for re-irradiation in the management of recurrent grade 4 glioma'. Together they form a unique fingerprint.

  • Cite this